Table 7.
Characteristics of studies Group 3 (Progressive bone loss)
| Studies | Characteristics | Results | ||||||
|---|---|---|---|---|---|---|---|---|
| Population | Sample (N)(P) | Sample (N)(DI) | Design follow-up | Time load (Y) | Diagnostic | Rate (P) (%) | Rate (DI) (%) | |
| Chappuis [28] | EU | 67 | 95 | Cohort | 20 | BOP + infection + BL progressive | Missing | 13.6842 |
| Gurgel [32] | SA | 155 | Missing | Cross-sectional | 5 | BOP/supp + PD > 5 mm + BL Rx visibl | 28.3871 | Missing |
| Francetti [35] | EU | 46 | 56 | Longitudinal | 5 | BOP/supp + increPD + BL Rx visible | 0 | 0 |
| French [37] | EU-USA | 2060 | 4591 | Cohort | 6–7 | BOP/suppuration + PD > 2 mm + BL > 1 mm least year | 11.6990 | 4.7048 |
| Pandolfi [54] | EU | 475 | 1991 | Cohort | 10 | BOP/supp + BL changes | 9.6842 | 12.09081 |
| Ravidá[59] | USA | 99 | 221 | Cohort | 10.6 ± 4.5 | BOP/supp + increPD + BL progressiv | 20.4 | 15 |
| Rinke [61] | EU | 89 | Missing | Cross-sectional | 5.5 ± 2 | BOP/supp + PD ≥ 4 mm + BL progress | 11.2359 | Missing |
| Rinke[62] | EU | 65 | 112 | Longitudinal | 6.8 + 1.96 | BOP/supp + PD ≥ 5 mm + BL progress | 9.2308 | Missing |
| Rodrigo [65] | EU | 22 | 68 | Cohort | 5 | BOP/supp + PD ≥ 4 mm + BL significa | Missing | 5.8823 |
| Simonis [72] | EU | 55 | 124 | Longitudinal | 10 to 16 | BOP + PD ≥ 5 mm + BL > 0.2 mm/year | Missing | 16.9355 |